Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial (Q39065872)
Jump to navigation
Jump to search
scientific article published on 22 December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial |
scientific article published on 22 December 2016 |
Statements
1 reference
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial (English)
1 reference
Bart Barlogie
1 reference
Antje Hoering
1 reference
Angela Dispenzieri
1 reference
S Vincent Rajkumar
1 reference
Robert Z Orlowski
1 reference
Muneer H Abidi
1 reference
Stephen P Kahanic
1 reference
Frederic Reu
1 reference
Rachael Sexton
1 reference
Brian G M Durie
1 reference
Joshua Epstein
1 reference
Mohan Thakuri
1 reference
Christopher M Reynolds
1 reference
22 December 2016
1 reference
1 reference
389
1 reference
519-527
1 reference
10068
1 reference
Identifiers
1 reference
1 reference
1 reference